Phase 1b/2 Study of Orally Administered Pexidartinib in Combination with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma. Joe S. Mendez , Adam L. Cohen , Midori Eckenstein , Randy L. Jensen , Lindsay M. Burt , Karen L. Salzman , Marc Chamberlain , Henry H. Hsu , Marguerite Hutchinson , Fabio Iwamoto , Keith L. Ligon , Maciej M. Mrugala , Michael Pelayo , Scott R. Plotkin , Vinay K. Puduvalli , Jeffrey Raizer , David A. Reardon , Michael Sterba , Tobias Walbert , Brian L. West , Eric T. Wong , Chao Zhang , Howard Colman NEURO-ONCOLOGY ADVANCES（2024）
关键词
CSF1R, glioblastoma, KIT, tumor microenvironment, pexidartinib
AI 理解论文
溯源树
样例
